STAT Plus: Momenta Pharma drug improves symptoms in patients with myasthenia gravis
ADOBE
In a mid-stage clinical trial, an experimental Momenta medicine significantly improved the symptoms of patients with generalized myasthenia gravis.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario